IBTA e-News July 2017 released

By 1st August 2017 August 28th, 2017 News archive
[30 July 2017] The IBTA's monthly e-News has now been released and has been emailed to all subscribers. To sign up to receive your copy, click here.

You can read the IBTA e-News July 2017 edition in full online here.

Some of the highlights from this month's include:

  • A comprehensive analysis of the entire genetic sequence of medulloblastoma tumours that has revealed the genetic changes that drive over 75% of the tumours.
  • Research showing unequal access to brain tumour treatment in Argentina.
  • The development of a new screening method to detect hitherto unseen brain tumour drug targets.
  • A meta-analysis of 65 studies that has revealed the overall survival of paediatric participants with high grade brain stem gliomas (such as DIPG) is two years is just 15.3%..
  • A special focus on upcoming and ongoing clinical trials that are open to patient enrollment, including a new arm of a phase 1b trial of Optune (a wearable Tumor Treating Fields device), the Pediatric MATCH ‘precision medicine’ trial, a recurrent anaplastic astrocytoma phase 3 trial (STELLAR) and a phase 1 trial of the gene therapy Ad-RTS-hIL-12 plus veledimex in recurrent glioblastoma.
  • The publication of the 2017 policy report from All.Can, Towards sustainable cancer care: Reducing inefficiencies and improving outcomes,  in the Journal of Cancer Policy.
  • A study offering potential explanations for why glioblastoma risk is increased in people with Alzheimer's disease.

Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to nearly 7,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences. You can sign up to receive the e-News every month by registering here.

To see an archive of existing e-News issues, click here.

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.